The enzymatic activities of brain COMT and methionine sulfoxide reductase are correlated in a COMT Val / Met allele-dependent fashion

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene-sex interactions in schizophrenia: focus on dopamine neurotransmission

  2014cited by this paper
• Cerebellar Stroke-manifesting as Mania

  2014cited by this paper
• Methionine sulfoxide reductase regulates brain catechol-O-methyl transferase activity.

  2014influential reference
• Concordance of psychiatric symptom ratings between a subject and informant, relevancy to post-mortem research

  2013cited by this paper
• Posterior cerebellar vermal deficits in bipolar disorder.

  2013cited by this paper
• First Manic Episode Revealing Cerebellar Stroke

  2012cited by this paper
• Methionine sulfoxide reductases and methionine sulfoxide in the subterranean mole rat (Spalax): characterization of expression under various oxygen conditions.

  2012cited by this paper
• Recurrence of bipolar mania is associated with catechol-O-methyltransferase Val(108/158)Met polymorphism.

  2011cited by this paper
• COMT Val158Met genotype as a risk factor for problem behaviors in youth.

  2010cited by this paper
• The impact of the Val158Met catechol-O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives

  2010cited by this paper
• Distribution and functions of catechol-O-methyltransferase proteins: do recent findings change the picture?

  2010cited by this paper
• Association between catechol-O-methyltransferase Val(108/158)Met polymorphism and psychotic features of bipolar disorder.

  2010cited by this paper
• Methionine sulfoxide reductase: A novel schizophrenia candidate gene

  2009cited by this paper
• Cerebellum and psychiatric disorders.

  2008cited by this paper
• Substrates of the methionine sulfoxide reductase system and their physiological relevance.

  2008cited by this paper
• Impact of Catechol-O-Methyltransferase on Prefrontal Brain Functioning in Schizophrenia Spectrum Disorders

  2007cited by this paper
• S-Adenosylmethionine-dependent Protein Methylation in Mammalian Cytosol via Tyrphostin Modification by Catechol-O-methyltransferase*

  2007cited by this paper
• Elevated levels of brain-pathologies associated with neurodegenerative diseases in the methionine sulfoxide reductase A knockout mouse

  2007cited by this paper
• Analysis of an association between the COMT polymorphism and clinical symptomatology in schizophrenia.

  2006cited by this paper
• Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond.

  2006cited by this paper
• Is the cerebellum relevant in the circuitry of neuropsychiatric disorders?

  2005cited by this paper
• Effect of Catechol-O-Methyltransferase val158met Genotype on Attentional Control

  2005cited by this paper
• Methionine sulfoxide reductases: ubiquitous enzymes involved in antioxidant defense, protein regulation, and prevention of aging-associated diseases.

  2005cited by this paper
• Catechol-O-Methyltransferase val158met Genotype Affects Processing of Emotional Stimuli in the Amygdala and Prefrontal Cortex

  2005cited by this paper
• Concordance of DSM-IV Axis I and II diagnoses by personal and informant's interview.

  2004cited by this paper
• Oxidative Inhibition of Human Soluble Catechol-O-methyltransferase*

  2004cited by this paper
• Aggressive behavior in schizophrenia is associated with the low enzyme activity COMT polymorphism: A replication study

  2003cited by this paper
• Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia.

  2003cited by this paper
• Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing.

  2003cited by this paper
• Catechol O-Methyltransferase (COMT) mRNA Expression in the Dorsolateral Prefrontal Cortex of Patients with Schizophrenia

  2003cited by this paper
• A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain.

  2003cited by this paper
• The underlying neurobiology of bipolar disorder.

  2003cited by this paper
• A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition.

  2002cited by this paper
• Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia.

  2002cited by this paper
• Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals

  2001cited by this paper
• Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia

  2001cited by this paper
• Aggressive behaviour in patients with schizophrenia is associated with catechol-O-methyltransferase genotype

  2001cited by this paper
• Oestrogen metabolism in lymphangioleiomyomatosis: catechol-O-methyltransferase pathway is not involved

  2000cited by this paper
• MRI Analysis of the Cerebellum in Bipolar Disorder: A Pilot Study

  1999cited by this paper
• Molecular cloning and functional expression of a human peptide methionine sulfoxide reductase (hMsrA)

  1999cited by this paper
• Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles.

  1999cited by this paper
• Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors.

  1999cited by this paper
• Overexpression of peptide-methionine sulfoxide reductase in Saccharomyces cerevisiae and human T cells provides them with high resistance to oxidative stress.

  1998cited by this paper
• Identification of sequence variants and analysis of the role of the catechol-O-methyl-transferase gene in schizophrenia susceptibility.

  1998cited by this paper
• Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder

  1998cited by this paper
• The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

  1998influential reference
• Analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association with aggressive and antisocial behavior.

  1997cited by this paper
• Modification of protein surface hydrophobicity and methionine oxidation by oxidative systems.

  1997cited by this paper
• Lack of association of catechol-O-methyltransferase (COMT) functional polymorphism in bipolar affective disorder

  1997cited by this paper
• No evidence for an association of affective disorders with high- or low-activity allele of catechol-o-methyltransferase gene.

  1997cited by this paper
• Expression and intracellular localization of catechol O-methyltransferase in transfected mammalian cells.

  1997cited by this paper
• Association analysis of the catechol O-methyltransferase gene and bipolar affective disorder.

  1997cited by this paper
• Peroxynitrite-mediated nitration of tyrosine residues in Escherichia coli glutamine synthetase mimics adenylylation: relevance to signal transduction.

  1996cited by this paper
• Bipolar disorders, dystonia, and compulsion after dysfunction of the cerebellum, dentatorubrothalamic tract, and substantia nigra.

  1996cited by this paper
• Methionine residues as endogenous antioxidants in proteins.

  1996cited by this paper
• No evidence for linkage of chromosome 22 markers to schizophrenia in southern African Bantu-speaking families.

  1996cited by this paper
• Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.

  1996cited by this paper
• No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity.

  1996cited by this paper
• Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme.

  1995cited by this paper
• Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters.

  1994influential reference
• Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form.

  1991cited by this paper
• Dopamine and norepinephrine activity in schizophrenia. An integrative perspective.

  1991cited by this paper
• Cerebellar atrophy in schizophrenia and affective disorder.

  1987cited by this paper
• Mania in two sisters with similar cerebellar disturbance.

  1985cited by this paper
• Characterization of Membrane‐Bound and Soluble Catechol‐O‐Methyltransferase from Human Frontal Cortex

  1984cited by this paper
• Psychiatric symptoms and cerebellar pathology.

  1983cited by this paper
• Distinct Cellular Localization of Membrane‐Bound and Soluble Forms of Catechol‐O‐Methyltransferase in Brain

  1983cited by this paper
• CEREBELLAR ATROPHY IN SCHIZOPHRENIA AND MANIA

  1981cited by this paper
• Enzymatic O-methylation of epinephrine and other catechols.

  1958cited by this paper

• No citing papers are available for this paper.